Ligand Binding Assay | CCF Assay | Antiviral Assay | |||||
---|---|---|---|---|---|---|---|
125I-RANTES | 125I-MIP-1α | 125I-MIP-1β | |||||
nM | |||||||
Ligand Kd (nM) | 0.59 ± 0.1 | 1.4 ± 0.5 | 0.4 ± 0.5 | ||||
Vicriviroc | 14 ± 1 | 11 ± 8 | 12 ± 3 | 1.2 ± 0.4 | 7.2 ± 2 | ||
Maraviroc | 9 ± 9 | 4 ± 1 | 3 ± 1 | 1.2 ± 0.5 | 1.4 ± 1 | ||
TAK779 | 4 ± 5 | 7.5 ± 5 | 4.5 ± 1 | 18 ± 2 | 13 ± 6 | ||
TAK 220 | 17 ± 5 | 7 ± 1 | 4,100 ± 320 | 6.1 ± 4 | 3 ± 4 | ||
Aplaviroc | 12 ± 2 | 8.5 ± 3 | 7.3 ± 0.2 | 1 ± 0.6 | 1 ± 1 |
CCF, cell-cell fusion.